- Home
- POAI vs SILO Comparison
POAI vs SILO Comparison
Compare POAI & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SILO
- Stock Information
- Founded
- POAI 2002
- SILO 2010
- Country
- POAI United States
- SILO United States
- Employees
- POAI N/A
- SILO N/A
- Industry
- POAI Industrial Specialties
- SILO Apparel
- Sector
- POAI Health Care
- SILO Consumer Discretionary
- Exchange
- POAI Nasdaq
- SILO Nasdaq
- Market Cap
- POAI 4.9M
- SILO 4.7M
- IPO Year
- POAI N/A
- SILO N/A
- Fundamental
- Price
- POAI $0.71
- SILO $0.82
- Analyst Decision
- POAI Hold
- SILO
- Analyst Count
- POAI 1
- SILO 0
- Target Price
- POAI N/A
- SILO N/A
- AVG Volume (30 Days)
- POAI 98.3K
- SILO 596.1K
- Earning Date
- POAI 11-12-2024
- SILO 11-12-2024
- Dividend Yield
- POAI N/A
- SILO N/A
- EPS Growth
- POAI N/A
- SILO N/A
- EPS
- POAI N/A
- SILO N/A
- Revenue
- POAI $1,484,223.00
- SILO $72,102.00
- Revenue This Year
- POAI N/A
- SILO $1.86
- Revenue Next Year
- POAI $569.48
- SILO N/A
- P/E Ratio
- POAI N/A
- SILO N/A
- Revenue Growth
- POAI N/A
- SILO N/A
- 52 Week Low
- POAI $0.55
- SILO $0.77
- 52 Week High
- POAI $3.76
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- POAI 47.04
- SILO 40.96
- Support Level
- POAI $0.69
- SILO $0.77
- Resistance Level
- POAI $0.80
- SILO $0.99
- Average True Range (ATR)
- POAI 0.06
- SILO 0.10
- MACD
- POAI -0.01
- SILO 0.00
- Stochastic Oscillator
- POAI 25.93
- SILO 23.30
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.